Multimodal Deep Learning for Predicting Post-Transfusion Mortality: Innovative Practice in Medical AI

This article introduces a medical AI study based on the MIMIC-IV dataset. It predicts 7-day post-transfusion mortality by fusing three modalities: tabular clinical data, irregular time-series signals, and clinical text. The study combines the LightGBM baseline model with a multimodal deep learning architecture and uses a Stacking ensemble strategy. This project provides an innovative solution for post-transfusion risk assessment, which is of great significance for optimizing clinical decision-making, resource allocation, and improving patient outcomes.

This study is based on the public MIMIC-IV (Medical Information Mart for Intensive Care) dataset, which contains a large amount of de-identified real clinical data and is an important resource for medical AI research. The study focuses on predicting mortality within 7 days after transfusion. This time window not only supports timely intervention but also captures delayed complications, reflecting a research approach that starts from actual clinical needs.

Multimodal Data Fusion: Integrate three key data modalities: 1. Tabular data (structured information such as demographics and laboratory results); 2. Irregular time series (dynamic indicators like heart rate and blood pressure, processed using specialized time-series modeling); 3. Clinical text (such as medical records, using the ClinicalBERT model to understand medical terminology).

Model Design: Use LightGBM as the baseline model; the multimodal deep learning uses modular encoders + fusion layers to generate a unified representation; combine the baseline and deep learning models through the Stacking ensemble strategy to leverage complementary advantages and improve generalization performance.

For common issues with real clinical data: 1. Data missing: Use domain knowledge inference, statistical imputation, and end-to-end learning for processing; set missing indicators for key features; 2. Class imbalance: Use appropriate sampling strategies and loss function design to avoid the model being biased towards the majority class; 3. Interpretability: Provide decision insights through attention visualization and feature importance analysis to enhance clinical trust.

1. Risk stratification: Help clinical teams stratify patients, strengthen monitoring for high-risk patients, and optimize resource allocation; 2. Decision support: Provide objective assessment for the trade-off between transfusion benefits and risks, assisting doctors in decision-making (not replacing clinical judgment); 3. Quality improvement: Identify key factors for adverse outcomes through feature importance analysis, guiding process optimization (such as transfusion indications and monitoring).

1. Data representativeness: MIMIC-IV data comes from U.S. ICUs, and generalization to other regions requires validation; 2. Ethical privacy: The study complies with data protocols, and actual deployment needs to consider informed consent, algorithm fairness, etc.; 3. Clinical validation: Prospective clinical trials are needed to verify the practical application value of the model, not just offline indicators.

This project reflects trends in medical AI: the importance of multimodal fusion, the combination of baseline and complex methods, and the path from public datasets to clinical translation. Multimodal deep learning has great potential in medical prediction, but it needs to address challenges such as data quality, interpretability, and clinical validation. We look forward to more research being translated into clinical value to improve patient outcomes.